Skip to main content

Closed

BNTX: BioNTech SE Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-28.0% / yr

Operating margin-52.1%

ROIC-7.5%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage-67.9×

Current ratio8.80×

BioNTech SE

BNTXNASDAQ Global Select·USD·Closed

BioNTech SE

BNTXNASDAQ·USD·Closed

$90.58

−2.44%

$90.58

−$2.27 (2.44%)

52W Range

25thpctl

Volume

0.76×avg

Mkt Cap

22.91BUSD

P/E

-15.6TTM

Div Yield

–ann

52W Range

25thpctl

Volume

0.76×avg

Market Cap

22.91BUSD

P/E Ratio

-15.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings